Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 4Unknown 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3Anxiety Disorders 3Pain 2Gastrointestinal Neoplasms 2Depression 2Acute Pain 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Otolaryngeal Cancer 1Mucositis 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1Agnosia 1

Interventions

acetaminophen, aspirin, caffeine drug combination 1Tapentadol 1Surveys and Questionnaires 1Oxycodone 1Ketorolac 1Ketamine 1Fentanyl 1Dosage Forms 1Bupivacaine 1Analgesics 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Agnosia × Ketamine × Clear all
NCT05597878 2026-06-01

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Terminated
58 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡